The Italian external quality assessment scheme in classical cytogenetics: Four years of activity

被引:5
作者
Floridia, G. [1 ]
Falbo, V. [1 ]
Censi, F. [1 ]
Tosto, F. [1 ]
Salvatore, M. [1 ]
Baroncini, A. [3 ]
Battaglia, P. [3 ]
Conti, A. [4 ]
Donti, E. [5 ]
La Starza, R. [6 ]
Nitsch, L. [4 ]
Pierluigi, M. [7 ]
Piombo, G. [7 ]
Susca, F. [8 ]
Mancini, M. [2 ]
Mecucci, C. [6 ]
Calzolari, E. [9 ]
Bricarelli, F. Dagna [7 ]
Guanti, G. [8 ]
Taruscio, D. [1 ]
机构
[1] Ist Super Sanita, Natl Ctr Rare Dis, Dept Cell Biol & Neurosci, IT-00161 Rome, Italy
[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Sect Haematol, Rome, Italy
[3] Gen Med Serv, Imola, Italy
[4] Univ Naples Federico 2, Dept Clin Pathol, Naples, Italy
[5] Univ Perugia, Dept Clin & Expt Med, Med Genet Unit, I-06100 Perugia, Italy
[6] Univ Perugia, IbiT Fdn, Fdn IRCCS Biotecnol Nel Trapianto, Dept Haematol, I-06100 Perugia, Italy
[7] EO Osped Galliera, Lab Human Genet, Genoa, Italy
[8] Univ Bari, Dept Internal Med & Publ Hlth, Med Genet Sect, Bari, Italy
[9] Univ Ferrara, Inst Med Genet, I-44100 Ferrara, Italy
关键词
external quality assessment; classical cytogenetics;
D O I
10.1159/000121401
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The Italian external quality assessment scheme in classical cytogenetics was started in 2001 as an activity funded by the National Health System and coordinated by the Italian Public Institute of Health. Objectives: The aim of our work is to present data from the first 4 years of activity, 2001-2004. Methods: Italian cytogenetics public laboratories were enrolled on a voluntary basis, and this nationwide program covered prenatal, postnatal and oncological diagnosis. The scheme is annual and retrospective; a panel of experts reviewed the quality of images and reports in order to assess technical, analytical and interpretative performance. Results: Over the 4-year period, the number of participating laboratories increased: from 36 in 2001,46 in 2002,49 in 2003 to 51 in 2004. The overall technical performance was satisfactory. Inadequacy or lack of information in reporting was the most frequent analytical inaccuracy identified in all parts of the scheme. However, the percentage of complete reports increased significantly during the period: by 36% in postnatal diagnosis between 2001 and 2004 (p < 0.001) and by 42% in oncological diagnosis between 2002 and 2004 (p = 0.003). Conclusions: Our experience reveals that participation in external quality assessment programs has significant advantages, helping to standardize and to assure quality in cytogenetic testing. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 22 条
[1]  
[Anonymous], Quality assurance procedures to verify compliance with the quality of ambient air measurements performed at monitoring network stations
[2]  
*ASS CLIN CYT, 2001, PROF GUID CLIN CYT
[3]  
*ASS CLIN CYT UK N, 1994, GUID CLIN CYT
[4]  
*ASS IT CIT MED, 1995, DIAGN CIT
[5]  
DALLAPICCOLA B, 2004, ANALYSIS, V2, P301
[6]  
Dallapiccola B, 2006, ANALYSIS, V6, P263
[7]   Genetic testing in Italy, year 2004 [J].
Dallapiccola, Bruno ;
Torrente, Isabella ;
Morena, Arnaldo ;
Dagna-Bricarelli, Franca ;
Mingarelli, Rita .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2006, 14 (08) :911-916
[8]  
Held KR, 2000, CYTOGENET CELL GENET, V91, P124
[9]  
HOWEL R, CURRENT SCOPE CYTOGE
[10]   Towards quality assurance and harmonization of genetic testing services in the European Union [J].
Ibarreta, D ;
Elles, R ;
Cassiman, JJ ;
Rodriguez-Cerezo, E ;
Dequeker, E .
NATURE BIOTECHNOLOGY, 2004, 22 (10) :1230-1235